Events – Abzena

Filter by year

Filter by topic

3rd Annual Biosimilars and Biobetters

  23 February 2017      Berlin, Germany

This 3rd Annual Summit brings together industry experts to explore strategies and gain insight into designing new biosimilar development programmes and analysis methods, clinical advancement, and new solutions for successful implementation in the market. It is a great environment for interactive networking, learning best practice, maintaining business relationships, and meeting new clients. We look forward […] Read more

PEGS Boston

  1 May 2017      Boston, USA

PEGS Summit will return to Boston May 1-5, 2017 for another inspiring weeklong event providing an exclusive platform for collaboration and discussion amongst a variety of academic and industry perspectives. Network with world-class experts from pharma, academia, and government to share information, case studies, and best practices covering a vast area of biologic drug development […] Read more

BIO San Diego 2017

  20 June 2017      San Francisco, CA, USA

The Golden State is the home of many firsts for the life sciences sector – the first biotechnology company, the first biotechnology public offering, the first biotechnology drug approved by the FDA, the first companion diagnostic company and the first agricultural biotechnology company – just to name a few. With over 242,000 Californians directly employed […] Read more

Antibody Engineering and Therapeutics

  10 December 2017      San Diego, CA, USA

Expand your pipeline of antibody therapeutics by hearing 125+ case studies, new data and industry updates from experts working across the entire spectrum of antibody development and production. Read more

Biotherapeutics Analytical Summit

  20 March 2017      Bethesda, USA

Abzena is attending Cambridge Healthtech Institute’s Eighth Annual Biotherapeutics Analytical Summit has grown from strength to strength year over year, covering a wide variety of product characterization topics ranging from post-translational modifications to bioassays, from process change to compliance, from developability to biosimilarity. This year, in response to industry demands gathered from extensive research and […] Read more

BIO-Europe Spring

  20 March 2017      Barcelona, Spain

Abzena has several members of it s BD team partnering at BIO Europe Spring 2017, the premier springtime partnering conference bringing together a “whoʼs who” from biotech, pharma and finance in Europe’s most innovative biopharma clusters Read more

ADC Summit: From Target to Therapeutics

  18 May 2017      Barcelona, Spain

Abzena is presenting at the 2nd Annual Antibody Drug Conjugates (ADC) Summit: From Target to Therapeutics The summit will shed light on current challenges, best practices and the inside view of the future of ADCs. It will discuss key findings, including critical insights, as well as recommendations for driving efficient strategies in the ADCs landscape. Read more

AACR

  1 April 2017      Washington, USA

Abzena are exhibiting at the AACR Annual Meeting highlights the best cancer science and medicine from institutions all over the world. Attendees are invited to stretch their boundaries, form collaborations, attend sessions outside their own areas of expertise, and learn how to apply exciting new concepts, tools, and techniques to their own research. Read more

American Biomanufacturing Summit

  23 May 2017      San Diego, CA, USA

Abzena is attending The American Biomanufacturing Summit is one of the most senior-level conferences and networking events in the industry. It is designed to provide biopharmaceutical executives with current trends, strategic insights and best practices in manufacturing, outsourcing, capacity management, quality assurance, quality control, regulatory compliance, operational excellence, supply chain and logistics. Network with over […] Read more

World ADC San Diego

  20 September 2017      San Diego, CA, USA

Widen the Therapeutic Index of Your ADC Program World ADC San Diego is the definitive industry forum for accelerating the development of more therapeutically effective antibody-drug conjugates. Covering the A-Z of ADCs from early discovery to clinical and manufacturing this conference will give you an incomparable amount of cutting-edge ADC insights, new data and experiences […] Read more

Interested in our services? Get In Touch